Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Sponsor: Medicis Pharmaceutical Corporation
A PHASE2 clinical study on Atopic Dermatitis, this trial is completed. The trial is conducted by Medicis Pharmaceutical Corporation and has accumulated 10 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 5 earlier versions
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE2
Phase: NA → PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Completed NA
-
Jun 2018 — Sep 2018 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medicis Pharmaceutical Corporation
- Wake Forest University
For direct contact, visit the study record on ClinicalTrials.gov .